Average Co-Inventor Count = 14.81
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (16 from 169 patents)
2. Celgene Corporation (1 from 550 patents)
17 patents:
1. 11358952 - Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith
2. 11292796 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
3. 10683298 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
4. 10167290 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
5. 9795607 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
6. 9771371 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
7. 9428509 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
8. 9346812 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
9. 9193692 - Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
10. 9079900 - Methods of synthesis and purification of heteroaryl compounds
11. 8907087 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
12. 8569494 - Methods of synthesis and purification of heteroaryl compounds
13. 8507492 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway
14. 8492381 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
15. 8372976 - Methods of treatment comprising the administration of heteroaryl compounds